Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes

BACKGROUND: Anakinra pharmacokinetics and pharmacodynamics were investigated in children and adolescents treated for systemic-onset juvenile idiopathic arthritis (SJIA) and autoinflammatory syndromes. METHODS: Anakinra was given subcutaneously at doses between 2 and 10 mg/kg (maximum 100 mg) per day...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Urien, Saik, Bardin, Christophe, Bader-Meunier, Brigitte, Mouy, Richard, Compeyrot-Lacassagne, Sandrine, Foissac, Franz, Florkin, Benoît, Wouters, Carine, Neven, Bénédicte, Treluyer, Jean-Marc, Quartier, Pierre
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3750485/
https://ncbi.nlm.nih.gov/pubmed/23915458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2050-6511-14-40
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki